Molecular Phenotyping and Novel Therapeutics in MDS

Molecular Phenotyping and Novel Therapeutics in MDS

Dr. Olatoyosi Odenike, associate professor of medicine, presents an overview of myelodysplastic syndrome and provides an update on front-line therapy.


Published

August 31, 2016

Created by

The University of Chicago Medicine

Related Presenters

Odenike

Olatoyosi Odenike, MD

Associate Professor of Medicine

Dr. Olatoyosi Sobulo Odenike is an expert in the care of adults with leukemia, chronic myeloproliferative diseases, and myelodysplastic syndromes. She specializes in all types of treatment for these diseases, including blood and bone marrow ...